1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 1:Summary of FA and MD (×10−3 mm2s−1) values quantified in patients with PKAN, their siblings, and age-matched healthy controls in deep gray matter nuclei and ALIC
Subject CN Putamen GP SN ALIC FA MD FA MD FA MD FA MD FA MD Control (n = 5) 0.10 ± 0.01 0.76 ± 0.02 0.08 ± 0.01 0.70 ± 0.01 0.10 ± 0.01 0.70 ± 0.01 0.19 ± 0.01 0.69 ± 0.11 0.35 ± 0.01 0.71 ± 0.02 Sibling (n = 5) 0.10 ± 0.01 0.77 ± 0.02 0.08 ± 0.01 0.71 ± 0.01 0.11 ± 0.02 0.72 ± 0.02 0.22 ± 0.02 0.69 ± 0.12 0.35 ± 0.01 0.72 ± 0.01 Patient (n = 7) 0.10 ± 0.01 0.77 ± 0.03 0.08 ± 0.01 0.70 ± 0.02 0.18 ± 0.03 0.75 ± 0.06 0.32 ± 0.02 0.67 ± 0.10 0.36 ± 0.01 0.71 ± 0.03 P valuea .17 .23 .31 .10 <.001 <.001 <.001 .71 .83 .16
a ANOVA.